Literature DB >> 22980060

Atrial fibrillation in heart failure.

Joel A Lardizabal1, Prakash C Deedwania.   

Abstract

Heart failure (HF) and atrial fibrillation (AF) are highly prevalent debilitating conditions that often coexist and are frequently encountered in clinical practice. The presence of chronic AF is a marker of worse prognosis in patients with HF, and the onset of new AF in those with chronic HF is associated with increased morbidity and mortality. Advances in the development of novel drugs, nonpharmacologic modalities, and therapeutic strategies, as well the increased understanding of the pathobiology of HF and AF, are key to mitigating the tremendous public health burden that is associated with these conditions. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22980060     DOI: 10.1016/j.mcna.2012.07.007

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  3 in total

1.  Effect of Sacubitril/Valsartan on Reducing the Risk of Arrhythmia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Ruxin Wang; Haowen Ye; Li Ma; Jinjing Wei; Ying Wang; Xiaofang Zhang; Lihong Wang
Journal:  Front Cardiovasc Med       Date:  2022-07-01

2.  Optimal Catheter Ablation Strategy for Patients with Persistent Atrial Fibrillation and Heart Failure: A Retrospective Study.

Authors:  Cheng-Ming Ma; Ye-Jian He; Wen-Wen Li; Hua-Min Tang; Shi-Yu Dai; Xiao-Meng Yin; Xian-Jie Xiao; Yun-Long Xia; Lian-Jun Gao; Yuan-Jun Sun; Zhong-Zhen Wang; Rong-Feng Zhang
Journal:  Cardiol Res Pract       Date:  2022-06-23       Impact factor: 1.990

3.  Predictive Value of HATCH Scoring and Waist-to-Height Ratio in Atrial Fibrillation Following Coronary Artery Bypass Operations Performed with Cardiopulmonary Bypass.

Authors:  Muhammed Savran; Mesut Engin; Orhan Guvenc; Hasan F Yüksek; Sadık Ahmet Sünbül; Tamer Turk; Yusuf Ata; Ufuk Aydın; Ahmet F Ozyazicioglu
Journal:  J Saudi Heart Assoc       Date:  2021-02-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.